Paper · 67564
Selective incorporation of H-2 antigenic determinants into Friend virus particles.
Bubbers JE and 1 other. Nature, 1977. Cited by 118 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Selective incorporation of H-2 antigenic determinants into Friend virus particles. Papers, record 67564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/67564
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Friend murine leukemia virus | Major topic |
| Histocompatibility Antigens | Major topic |
| Membrane Proteins | Major topic |
| Animals | |
| Epitopes | |
| Glycoproteins | |
| Mice | |
| Mice, Inbred Strains | |
| Viral Proteins | |
| Virus Replication |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,430,891 | Host genetic control of recovery from Friend leukemia virus-induced splenomegaly: mapping of a gene within the major histocompatability complex. | J Exp Med | 1974 | https://conductscience.org/library/papers/4430891 | PubMed |
| 3 | 4,135,911 | A proposed nomenclature for the virion proteins of oncogenic RNA viruses. | Virology | 1974 | https://conductscience.org/library/papers/4135911 | PubMed |
| 4 | 1,194,854 | Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice. | J Exp Med | 1975 | https://conductscience.org/library/papers/1194854 | PubMed |
| 5 | 1,082,989 | T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2. | Nature | 1976 | https://conductscience.org/library/papers/1082989 | PubMed |
| 6 | 47,901 | H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;. | J Exp Med | 1975 | https://conductscience.org/library/papers/47901 | PubMed |
| 7 | 61,285 | Interactions of vesicular stomatitis virus with murine cell surface antigens. | J Virol | 1976 | https://conductscience.org/library/papers/61285 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,468,748 | Mammalian Lipopolysaccharide Receptors Incorporated into the Retroviral Envelope Augment Virus Transmission. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/26468748 | PubMed |
| 22,457,924 | Anti-H-2 antibodies induced by syngeneic immunization. | Immunogenetics | 1980 | https://conductscience.org/library/papers/22457924 | PubMed |
| 22,312,342 | Murine leukemia viruses: objects and organisms. | Adv Virol | 2011 | https://conductscience.org/library/papers/22312342 | PubMed |
| 22,231,291 | XMRV and prostate cancer--a 'final' perspective. | Nat Rev Urol | 2012 | https://conductscience.org/library/papers/22231291 | PubMed |
| 20,966,126 | XMRV: a new virus in prostate cancer? | Cancer Res | 2010 | https://conductscience.org/library/papers/20966126 | PubMed |
| 18,297,655 | Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents. | Proteomics | 2008 | https://conductscience.org/library/papers/18297655 | PubMed |
| 17,504,532 | Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents. | Retrovirology | 2007 | https://conductscience.org/library/papers/17504532 | PubMed |
| 12,947,040 | The Trojan exosome hypothesis. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12947040 | PubMed |
| 11,152,488 | Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1. | J Virol | 2001 | https://conductscience.org/library/papers/11152488 | PubMed |
| 9,420,272 | Efficient infection mediated by viral receptors incorporated into retroviral particles. | J Virol | 1998 | https://conductscience.org/library/papers/9420272 | PubMed |
1 to 10 of 39
See all 39 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/67564
GET https://conductscience.org/api/papers/v1/67564/cited_by?page=2